CIK 0001701108 · Non-accelerated filer<br>Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- 4 Insider Changes in Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Delisting notice
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 8-K Event Results of operations · Exit or restructuring costs · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
Page 4 of 26 · 519 filings